Discovery of triazolinone non-nucleoside inhibitors of HIV reverse transcriptase
Authors:
- Zachary K. SweeneyZSZachary K. Sweeney
- Sahaja AcharyaSASahaja Acharya
- Andrew BriggsABAndrew Briggs
- James P. DunnJDJames P. Dunn
- Todd R. ElworthyTETodd R. Elworthy
- Jennifer FretlandJFJennifer Fretland
- Anthony M. GiannettiAGAnthony M. Giannetti
- Gabrielle HeilekGHGabrielle Heilek
- Yu LiYLYu Li
- Ann C. KaiserAKAnn C. Kaiser
- Michael MartinMMMichael Martin
- Y. David SaitoYSY. David Saito
- 1 August 2008
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (15) , 4348-4351
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Discovery and optimization of pyridazinone non-nucleoside inhibitors of HIV-1 reverse transcriptaseBioorganic & Medicinal Chemistry Letters, 2008
- Additional level of information about complex interaction between non-nucleoside inhibitor and HIV-1 reverse transcriptase using biosensor-based thermodynamic analysisBioorganic & Medicinal Chemistry, 2007
- Ligand efficiency indices for effective drug discoveryExpert Opinion on Drug Discovery, 2007
- RilpivirineDrugs of the Future, 2007
- Fragment-Based Drug Design: How Big Is Too Big?Journal of Medicinal Chemistry, 2006
- Deconstructing fragment-based inhibitor discoveryNature Chemical Biology, 2006
- Current Status of the Non-nucleoside Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Type 1Current Topics in Medicinal Chemistry, 2004
- Ligand efficiency: a useful metric for lead selectionDrug Discovery Today, 2004
- Mechanism of Inhibition of HIV-1 Reverse Transcriptase by Nonnucleoside InhibitorsScience, 1995